Sellas Life Sciences Group Inc Cash Flow-to-Debt Ratio
Sellas Life Sciences Group Inc cash flow-to-debt ratio. Sellas Life Sciences Group Inc (SLS) has a Cash Flow-to-Debt Ratio of -0.98x as of June 2026, meaning its operating cash flow of $-7.59 Million could theoretically repay -1% of its total liabilities ($7.73 Million) in one year. Check how aggressively does Sellas Life Sciences Group Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Sellas Life Sciences Group Inc (2007–2025)
Cash flow-to-debt ratio of Sellas Life Sciences Group Inc from 2007 to 2025. Historical debt coverage capacity for Sellas Life Sciences Group Inc across 19 annual periods. Check Sellas Life Sciences Group Inc (SLS) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Sellas Life Sciences Group Inc Cash Flow-to-Debt Ratio by Year (2007–2025)
Sellas Life Sciences Group Inc cash flow-to-debt ratio by year from 2007 to 2025. Year-by-year debt coverage analysis for Sellas Life Sciences Group Inc. For the full cash flow conversion analysis, see Sellas Life Sciences Group Inc cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.80x | $-28.39 Million | $7.47 Million | ▼ -6.9% |
| 2024 | -3.55x | $-35.40 Million | $9.97 Million | ▼ -60.5% |
| 2023 | -2.21x | $-31.41 Million | $14.20 Million | ▼ -49.6% |
| 2022 | -1.48x | $-23.81 Million | $16.09 Million | ▲ +65.4% |
| 2021 | -4.28x | $-26.02 Million | $6.08 Million | ▼ -643.1% |
| 2020 | -0.58x | $-10.42 Million | $18.09 Million | ▲ +65.7% |
| 2019 | -1.68x | $-17.64 Million | $10.52 Million | ▲ +35.6% |
| 2018 | -2.61x | $-30.42 Million | $11.67 Million | ▼ -646.2% |
| 2017 | -0.35x | $-10.99 Million | $31.46 Million | ▲ +71.1% |
| 2016 | -1.21x | $-44.91 Million | $37.15 Million | ▼ -72.3% |
| 2015 | -0.70x | $-48.16 Million | $68.63 Million | ▲ +28.9% |
| 2014 | -0.99x | $-42.87 Million | $43.43 Million | ▼ -180.3% |
| 2013 | -0.35x | $-28.91 Million | $82.09 Million | ▲ +54.3% |
| 2012 | -0.77x | $-20.96 Million | $27.23 Million | ▼ -9.5% |
| 2011 | -0.70x | $-14.67 Million | $20.86 Million | ▲ +65.4% |
| 2010 | -2.03x | $-10.26 Million | $5.05 Million | ▲ +4.8% |
| 2009 | -2.14x | $-11.77 Million | $5.51 Million | ▲ +68.5% |
| 2008 | -6.78x | $-9.43 Million | $1.39 Million | ▼ -48.4% |
| 2007 | -4.57x | $-6.05 Million | $1.32 Million | — |